82813-85-2 Usage
Uses
Used in Organic Synthesis:
2,2-dimethyltetrahydrothieno[3,4-d][1,3]dioxole 5,5-dioxide is used as a building block in organic synthesis for its capacity to form complex molecular structures. Its unique combination of sulfur and oxygen atoms, along with the presence of methyl groups, makes it a versatile component in the creation of novel organic compounds.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 2,2-dimethyltetrahydrothieno[3,4-d][1,3]dioxole 5,5-dioxide is used as a potential precursor for the development of new drugs. Its distinctive molecular features may contribute to the discovery of innovative therapeutic agents, particularly in the areas of medicinal chemistry where unique structures can lead to new pharmacological properties.
Used in Materials Science:
2,2-dimethyltetrahydrothieno[3,4-d][1,3]dioxide is utilized in materials science for its potential to contribute to the development of new materials with specific properties. 2,2-dimethyltetrahydrothieno[3,4-d][1,3]dioxole 5,5-dioxide's sulfur and oxygen content, along with its cyclic structure, may offer unique characteristics that could be harnessed in the creation of advanced materials with applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 82813-85-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,2,8,1 and 3 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 82813-85:
(7*8)+(6*2)+(5*8)+(4*1)+(3*3)+(2*8)+(1*5)=142
142 % 10 = 2
So 82813-85-2 is a valid CAS Registry Number.
82813-85-2Relevant academic research and scientific papers
STEREOSPECIFIC SYNTHESIS OF ETHERS OF HYDROXYTETRAHYDROTHIOPHENE-1,1-DIOXIDES USING INTERPHASE CATALYSIS
Tolstikov, G. A.,Novitskaya, N. N.,Shul'ts, E. E.
, p. 1129 - 1134 (2007/10/02)
Methods have been developed for the stereospecific synthesis of O-benzyl- and O-methyl-derivatives of hydroxytetrahydrothiophene-1,1-dioxides in the presence of phase transfer catalysts.
